Charles River Labs (CRL) PT Raised to $128 at Barclays
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $278.06 -1.28%
Rating Summary:
23 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Rating Summary:
23 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Join SI Premium – FREE
Barclays analyst Jack Meehan raised the price target on Charles River Labs (NYSE: CRL) to $128.00 (from $120.00) while maintaining a Equalweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Charles River Leverages Expertise in Rapid and In Vitro Methods to Reduce Cell Banking Timelines
- salesforce.com (CRM) PT Raised to $260 at UBS Following Dreamforce Conference
- Bank of Nanjing (601009:CH) PT Raised to RMB13.50 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
